Why "Patient Recruitment Company" Means Something Different In 2026
Clinical trial enrollment delays are the single biggest reason drug development timelines slip, which is why the term patient recruitment company now covers four genuinely different business models instead of one crowded category of similar vendors. Nearly 80% of clinical trials fail to meet their original patient enrollment timelines and every month a trial sits under-enrolled costs a sponsor real money in site overhead and delayed revenue. Some "patient recruitment companies" are databases matching pre-registered patients to studies. Some are paid-media agencies running geo-targeted Meta and Google campaigns that still have to clear IRB approval before a single ad goes live. Others are CRO divisions bundling recruitment into a broader trial-operations contract, or AI platforms mining electronic health records to surface eligible patients at the site level instead of advertising to the public at all.
Picking the wrong model for a trial's specific bottleneck, whether that is an undersized site network, a weak digital funnel, or a thin patient database, means paying for capabilities a sponsor does not need while the real gap goes unaddressed. This guide breaks down the four business models behind clinical trial patient recruitment, compares seven companies working across them, and covers what recruitment actually costs, what a red flag looks like, and how to decide whether to keep recruitment in-house. No agency paid for placement.
Who This Guide Is For (And Not For)
This guide is for:
- CRO business development and clinical operations leads comparing recruitment vendors for an active or upcoming trial
- Pharmaceutical and biotech sponsors deciding between a recruitment platform, a paid-media agency, a CRO-bundled model, or an AI/EHR-matching tool
- Marketing and clinical operations leaders who need to benchmark cost per randomized patient or cost per lead against what these companies publish
- Teams already running, or about to launch, paid-media patient recruitment campaigns and evaluating whether to bring in a specialist
This guide is not for:
- Patients looking to find or enroll in a trial themselves (start at ClinicalTrials.gov or ask a treating physician)
- Sponsors needing full-service CRO capabilities beyond recruitment, such as protocol design, data management, or safety monitoring
- Trials running exclusively outside the United States, where several of these companies have limited or no presence
- Teams wanting a single-channel vendor, like a call center or an SEO-only shop, rather than a recruitment-specific partner
How We Evaluated These Companies
We compared these seven companies on how they actually get patients to randomization, not on marketing claims. Criteria: the recruitment mechanism itself (database, paid media, CRO bundle, site network, or AI matching), geographic reach across United States and international sites, depth in specific therapeutic areas, readiness to operate inside IRB and HIPAA-adjacent approval processes, and whether a company publishes documented enrollment outcomes rather than vague promises. We reviewed public case studies, published service pages, and pricing information where available, and prioritized companies whose own materials name a specific mechanism (a database, a physician network, an ad account) over a general claim to "recruit patients." No company paid for placement on this list.
Quick Comparison: Best Clinical Trial Patient Recruitment Companies
The 6 Best Clinical Trial Patient Recruitment Companies
Clariness
Headquarters: Munich, Germany
Best For: Enterprise-Scale Multi-Country Patient Recruitment
Clariness is a clinical trial patient recruitment platform that specializes in enrolling patients across large, multi-country studies for pharmaceutical sponsors and CROs.
Clariness runs patient databases, digital recruitment campaigns, pre-screening, and site referral networks across 50+ countries, drawing on experience from 1,000+ clinical trials. A managed-services option lets sponsors hand off the full recruitment funnel, from campaign to pre-screened lead, rather than just buying access to the database. That combination of scale and hands-off delivery is built for sponsors coordinating enrollment across many countries and languages at once, where a single-market agency would need to build that infrastructure from scratch.
Key Services
- Patient databases and CRM for cross-study matching
- Digital recruitment campaigns across paid social and display
- Pre-screening and eligibility triage
- Site referral networks
- Feasibility studies
- Managed recruitment services
- Multi-language patient communications
Pros
- 1,000+ trials and 50+ country reach outscale most single-market competitors
- Managed-services option gives sponsors one accountable vendor
- Established pre-screening infrastructure reduces site-level burden
- Multi-language capability supports global protocols
Cons
- Enterprise scale and pricing can be more than a single-market US trial needs
- Less depth in hyperlocal, city-by-city paid media execution than a dedicated paid-media agency
Verdict: Clariness is the strongest choice for sponsors running trials across a dozen countries at once, since its recruitment infrastructure and global footprint outscale what any single-market agency can offer.
Continuum Clinical
Headquarters: United States
Best For: Large-Scale Multi-Country CRO Recruitment Operations
Continuum Clinical is a recruitment-focused CRO that specializes in bundling patient recruitment with broader clinical trial operations for pharmaceutical sponsors running large, multi-country studies.
For sponsors who would rather fold recruitment into a single CRO relationship than manage a separate specialist vendor, Continuum Clinical handles feasibility, site identification, and enrollment campaign management under one contract. That bundled structure suits sponsors running trials across several countries at once, where coordinating a standalone recruitment agency alongside a separate CRO adds a layer of vendor management most large studies would rather avoid.
Key Services
- Recruitment strategy and feasibility assessment
- Site identification and activation
- Patient recruitment campaign management
- Multi-country study coordination
- Enrollment forecasting and reporting
Pros
- One contract covers recruitment alongside broader CRO operations
- Feasibility and site-identification work already integrated
- Built for multi-country, multi-site scale
- Single point of accountability for sponsors
Cons
- Less specialized than a pure-play recruitment platform or paid-media agency
- Bundled pricing can make recruitment-specific costs harder to isolate
Verdict: For sponsors who want recruitment folded into a single CRO contract rather than managed as a separate line item, Continuum Clinical is hard to beat.
Elligo Health Research
Headquarters: Austin, TX
Best For: Physician-Network Patient Access Via Community Practices
Elligo Health Research is an integrated research organization that specializes in turning community physician practices into clinical trial sites, giving sponsors direct access to patients already being treated for the target condition.
Instead of recruiting patients cold through ads, Elligo activates practices where eligible patients are already established and the physician relationship already exists. That model suits sponsors who need faster site startup and a lower-outreach-heavy path to enrollment, trading the reach of a public ad campaign for the trust already built into an existing patient-physician relationship across its United States practice network.
Key Services
- Site network activation
- Community physician practice integration
- Patient identification within existing practice populations
- Site startup and regulatory support
- Study coordination
- Sponsor-to-site matching
Pros
- Patients already in-system with an established relationship with the physician
- Faster site activation than building a site network from scratch
- Broad community-practice footprint
- Reduces reliance on cold outbound outreach
Cons
- Reach limited to conditions with a strong existing-patient population in partner practices
- Less useful for rare-condition trials needing broad geographic ad-based outreach
Verdict: When a sponsor needs to activate community physicians as trial sites rather than build a site network from scratch, Elligo Health Research is the partner to call.
Deep6 AI
Headquarters: Pasadena, CA
Best For: AI/EHR-Based Site-Level Patient Matching
Deep6 AI is an artificial intelligence platform that specializes in mining electronic health record data to surface eligible patients for research sites before a single recruitment ad runs.
This is not a patient-facing model; it is a backend, site-facing one. Deep6 AI feeds site staff a ranked list of candidates matched to protocol criteria using data already sitting in the EHR, cutting the manual chart-review burden that normally falls on research coordinators. It works best as a complement to outbound recruitment rather than a replacement for it, particularly for feasibility and cohort-sizing questions before a trial even opens.
Key Services
- EHR data mining and protocol matching
- Site-level candidate ranking
- Feasibility and cohort sizing
- Integration with site EHR systems
- Real-time eligibility screening
- Site staff workflow tools
Pros
- Surfaces patients a site already has a relationship with
- Reduces manual chart-review burden on coordinators
- Useful for feasibility and cohort sizing before a trial opens
- Complements outbound recruitment rather than competing with it
Cons
- Not a substitute for outbound recruitment when a site's existing population does not meet enrollment targets
- Value depends on the depth and quality of a site's EHR data
Verdict: Nothing on this list matches Deep6 AI for mining existing EHR data to surface eligible patients before a single recruitment ad ever runs.
SubjectWell
Headquarters: United States
Best For: Multi-Channel Patient Marketplace For Chronic-Condition Trials
SubjectWell is a patient recruitment marketplace that specializes in connecting people managing chronic conditions to relevant clinical trials through a patient-facing platform and referral network.
SubjectWell pairs a patient-facing marketplace with HCP referral programs and hosted pre-screening, built for chronic conditions where patients are frequently already searching online for treatment options. That combination gives sponsors a channel where demand is partly self-generated by patients browsing available studies across the United States, rather than entirely dependent on outbound advertising to build awareness from zero.
Key Services
- Patient-facing trial marketplace
- HCP referral programs
- Hosted pre-screening
- Chronic-condition patient community outreach
- Multi-channel campaign management
- Referral partner network
Pros
- Patient-facing marketplace captures people already searching for options
- Built-in HCP referral channel supplements paid outreach
- Hosted pre-screening reduces site intake burden
- Chronic-condition focus builds channel-specific expertise
Cons
- Chronic-condition focus makes it a weaker fit for acute or rare-condition trials
- Less hyperlocal geographic targeting depth than a dedicated paid-media agency
Verdict: SubjectWell is the most specialized pick for sponsors running chronic-condition trials that need a patient-facing marketplace plus a built-in HCP referral channel.
StudyKIK
Headquarters: United States
Best For: Mobile App And Social-First Patient Outreach
StudyKIK is a digital advertising agency that specializes in mobile app and social media outreach for clinical trial patient recruitment.
StudyKIK combines a branded mobile app, where patients browse and enroll in trials directly, with social advertising on Meta and Instagram. That is a lighter-weight engagement model than an enterprise platform or a multi-city paid-media account, which makes it a workable fit for sponsors running a single trial across the United States rather than a global multi-study portfolio.
Key Services
- Branded mobile recruitment app
- Social media advertising
- Patient community engagement
- Single-trial campaign management
- Local market targeting
- Patient re-engagement campaigns
Pros
- Mobile-first approach meets patients where they already are
- Lighter-weight engagement model suits single-trial sponsors
- Established social advertising expertise
- Lower barrier to entry than an enterprise platform
Cons
- Less built for six-figure-per-month, multi-city scale than an agency purpose-built for that volume
- App-based reach depends on patients already having, or downloading, the app
Verdict: Sponsors running a single trial on a tight budget will not find a better mobile-and-social recruitment partner than StudyKIK.
What Clinical Trial Patient Recruitment Costs In 2026
Cost per lead for clinical trial ads typically runs $20 to $45 depending on condition, format, and messaging angle, but CPL alone is a misleading number because it ignores how many leads actually convert to randomized patients.
Pricing structures vary by model. Recruitment platforms like Clariness typically charge a mix of platform access fees and per-referral or managed-service rates. CRO-bundled recruitment from a company like Continuum Clinical usually rolls into the overall study budget rather than sitting as a standalone line item. Paid-media agencies bill retainer plus ad spend, with the retainer covering creative production, campaign management, and IRB-compliant asset iteration. Site networks like Elligo Health Research often price around site activation and study milestones rather than per-lead metrics. Budget for enrollment to take longer and cost more than the initial estimate. It almost always does.
Platform, Agency, Or CRO? The Business Models Behind Patient Recruitment
Clinical trial patient recruitment splits into four distinct business models, and confusing them is the most common reason sponsors pick the wrong partner.
Recruitment platforms run pre-built patient databases and matching technology. A patient, or a physician on their behalf, registers interest once, and the platform matches that record against open trial criteria across many sponsors at once. Clariness and SubjectWell both work this way, though SubjectWell layers in a marketplace and HCP referral model while Clariness leans toward managed enterprise services at global scale. The technology end of this category stretches to AI tools like Deep6 AI, which mines a research site's own electronic health record data to surface eligible patients internally instead of advertising to the public: a site-facing variant of the same core idea, matching existing data against protocol criteria rather than building a public funnel.
Paid-media agencies build and run advertising campaigns, usually on Meta and Google, that drive patients to a screening form. Creative strategy, zip-code-level geo-targeting, and IRB-approved ad copy determine cost per lead here. StudyKIK leans on a branded mobile app plus social advertising sized for single-trial sponsors.
CRO recruitment divisions bundle patient recruitment into a broader contract research relationship. Continuum Clinical fits this model, folding feasibility, site identification, and recruitment into one CRO contract instead of a separate vendor relationship.
Physician and site networks take the opposite approach: rather than advertising for new patients, they activate community physician practices as trial sites, drawing on patients already established in that practice. Elligo Health Research is the clearest example, converting existing clinician-patient relationships into trial access instead of building a public-facing funnel.
None of these models is universally best. The right one depends on which part of a specific trial's funnel is actually broken.
Red Flags When Choosing A Patient Recruitment Partner
A vague enrollment guarantee with no mechanism behind it is the clearest warning sign. Any partner promising a specific enrollment number without explaining the funnel, from ad click to screened to randomized, is selling optimism, not a process.
No clear IRB workflow is a close second. Every clinical trial ad requires IRB approval before it runs, and a partner without a plan for that reality will slow a launch to a crawl. Ask specifically how they batch creative submissions, whether they plan briefs far enough in advance to absorb approval timelines, and whether their creative formats are modular enough that revising one element does not force a full resubmission. A partner who has never had an ad rejected has probably never run enough volume to know what a real IRB or platform review process actually looks like.
Watch for a partner with no geographic or site-level targeting capability. Running one generic national campaign for a six-site trial wastes spend on markets nowhere near a site. And watch for opaque reporting: a partner who reports leads but not screen rate, disqualification reasons, or randomization rate is hiding the metric that actually determines whether the engagement is working.
In-House Recruitment Vs. Outsourcing: When To Bring In A Specialist
A CRO or sponsor with one trial, one site, and a marketing team that already runs paid social can often manage recruitment in-house, at least at first. The calculation changes once a trial runs across multiple sites and cities, once enrollment falls behind schedule, or once the creative and media-buying workload outpaces what an internal team can iterate on fast enough to keep cost per lead down.
The clearest signal that it is time to bring in a specialist: enrollment is behind timeline and the in-house team cannot say why, whether that is weak creative, poor targeting, an IRB bottleneck, or a genuine shortage of eligible patients in the target geography. A specialist partner should be able to diagnose which of those it is within the first few weeks of an engagement, not months in.
The same standard applies outside the clinical-trial niche: hospitals and healthcare SaaS brands now vet partners on regulatory-plus-media fluency, not on portfolio size alone, and that same combination (regulatory literacy plus real paid-media skill) is exactly what separates a recruitment specialist from a generalist agency bolting on a healthcare client.
Final Verdict: How To Choose The Right Recruitment Partner
The right recruitment partner depends on which part of the enrollment funnel is actually broken, not on which company has the biggest brand. Sponsors running large multi-country studies with a thin patient database should look at Clariness first, given its 1,000+ trial track record and global infrastructure. Sponsors who would rather manage recruitment inside one CRO contract should talk to Continuum Clinical. Trials that can lean on existing physician-patient relationships instead of cold outreach are a stronger fit for Elligo Health Research, and sites sitting on an underused EHR database before a trial even opens should look at Deep6 AI. Chronic-condition trials benefit from SubjectWell's marketplace and referral model, and single-trial sponsors on a tighter budget should consider StudyKIK's mobile-and-social approach.
Whichever model fits, the fastest way to find out where a specific trial's enrollment bottleneck actually sits is to build a plan around randomized-patient cost instead of chasing a generic recruitment pitch.
FAQ
What Are The Best Clinical Trial Patient Recruitment Companies In 2026?
The best clinical trial patient recruitment companies in 2026 include Clariness, Continuum Clinical, Elligo Health Research, Deep6 AI, SubjectWell, and StudyKIK. Each is built around a different recruitment model: patient database, paid media, CRO-bundled, physician network, AI/EHR matching, and patient marketplace.
What's The Difference Between A Clinical Trial Recruitment Platform, Agency, And CRO?
A recruitment platform like Clariness runs a pre-built patient database and matches registrants to open trials. A paid-media agency builds and runs advertising campaigns that drive patients to a screening form. A CRO recruitment division, like Continuum Clinical, bundles recruitment into a broader trial-operations contract rather than selling it as a standalone service.
How Much Does Clinical Trial Patient Recruitment Cost?
Cost per lead for clinical trial advertising typically runs $20 to $45, varying by condition, creative format, and messaging angle. Cost per randomized patient, which accounts for screening drop-off between lead and enrollment, is the number that actually determines ROI.
What Is A "Randomized Patient" And Why Is It The Metric That Matters?
A randomized patient is someone who has cleared screening, met eligibility criteria, and been formally assigned to a study arm, not just someone who clicked an ad or filled out a lead form. Cost per lead can look excellent while cost per randomized patient tells a very different story if screening drop-off is high, which is why sponsors should track both.
Can A CRO Handle Patient Recruitment In-House, Or Is A Specialist Worth It?
A single-site, single-trial CRO with an in-house marketing team that already runs paid social can often manage recruitment without a specialist, at least initially. Once a trial spans multiple sites and cities, or enrollment falls behind schedule and the internal team cannot diagnose why, bringing in a specialist recruitment partner usually pays for itself in time saved.
How Do You Evaluate A Recruitment Company Before Hiring One?
Ask for the recruitment mechanism specifically (database, paid media, CRO bundle, site network, or AI matching), documented enrollment outcomes from a comparable therapeutic area, their IRB approval workflow, and whether they report screen rate and randomization rate, not just lead volume. A company that only offers a CPL benchmark without a randomization number is telling half the story.
Does Clinical Trial Advertising Need IRB Approval Before It Runs?
Yes. Every clinical trial ad requires IRB approval before it can launch, which is why experienced recruitment partners batch creative submissions and plan briefs far enough in advance to absorb approval timelines, and build modular creative so revising one element does not force a full resubmission.